D6567

DRF 2519

≥98% (HPLC), solid

• Sinónimos: 5-[[4-[2-(4-Oxo-2H-1,3-benzoxazin3(4H)-yl)ethoxy]phenyl]methyl2,4-thiazolidinedione
• Fórmula empírica (notación de Hill): C₂₀H₁₈N₂O₅S
• Peso molecular: 398.43
• MDL number: MFCD06798336
• UNSPSC Code: 12352200
• PubChem Substance ID: 24894036

Propiedades

• assay: ≥98% (HPLC)
• form: solid
• storage condition: under inert gas
• color: white
• solubility: DMSO: ≥10 mg/mL
• storage temp.: 2-8°C
• SMILES string: O=C1NC(=O)C(Cc2ccc(OCCN3COc4ccccc4C3=O)cc2)S1

Descripción

Biochem/physiol Actions

DRF-2519 is a dual PPARα/γ activator. DRF-2519 has better reduction of plasma insulin, triglyceride, and free fatty acid levels than those treated with rosiglitazone.

Información de seguridad

• Storage Class: 13 - Non Combustible Solids
• wgk_germany: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: Eyeshields, Gloves, type N95 (US)